Oncoinvent Appoints Zuzana Jiráková Trnková Chief Medical Officer
Oncoinvent appointed Zuzana Jiráková Trnková as chief medical officer.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
4 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Oncoinvent appointed Zuzana Jiráková Trnková as chief medical officer.
Oncoinvent says Trnková will lead Phase 3 preparations for Radspherin. She brings more than 20 years of clinical development experience.
Oncoinvent said Dr Zuzana Jiráková Trnková will lead Phase 3 preparations for Radspherin.